New Risk • Jun 17
New major risk - Financial position The company's debt is not well covered by operating cash flow. Currently running at an operating cash loss. This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). High level of non-cash earnings (65% accrual ratio). Upcoming Dividend • Jun 10
Upcoming dividend of ₹0.50 per share Eligible shareholders must have bought the stock before 17 June 2026. Payment date: 24 July 2026. Payout ratio is a comfortable 7.6% but the company is not cash flow positive. Trailing yield: 0.1%. Lower than top quartile of Indian dividend payers (1.5%). Lower than average of industry peers (0.8%). Annonce • May 27
Madhya Bharat Agro Products Limited, Annual General Meeting, Jun 24, 2026 Madhya Bharat Agro Products Limited, Annual General Meeting, Jun 24, 2026, at 11:00 Indian Standard Time. Annonce • Apr 16
Madhya Bharat Agro Products Limited to Report Q4, 2026 Results on Apr 17, 2026 Madhya Bharat Agro Products Limited announced that they will report Q4, 2026 results on Apr 17, 2026 Valuation Update With 7 Day Price Move • Apr 03
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₹532, the stock trades at a trailing P/E ratio of 44.5x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 80% over the past three years. Reported Earnings • Oct 10
Second quarter 2026 earnings released: EPS: ₹3.48 (vs ₹1.58 in 2Q 2025) Second quarter 2026 results: EPS: ₹3.48 (up from ₹1.58 in 2Q 2025). Revenue: ₹4.52b (up 62% from 2Q 2025). Net income: ₹304.6m (up 120% from 2Q 2025). Profit margin: 6.7% (up from 5.0% in 2Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has increased by 24% per year, which means it is well ahead of earnings. Upcoming Dividend • Aug 19
Upcoming dividend of ₹0.50 per share Eligible shareholders must have bought the stock before 26 August 2025. Payment date: 02 October 2025. Payout ratio is a comfortable 7.6% but the company is not cash flow positive. Trailing yield: 0.1%. Lower than top quartile of Indian dividend payers (1.3%). Lower than average of industry peers (0.7%). Annonce • Aug 08
Madhya Bharat Agro Products Limited announces Annual dividend, payable on October 02, 2025 Madhya Bharat Agro Products Limited announced Annual dividend of INR 0.5000 per share payable on October 02, 2025, ex-date on August 26, 2025 and record date on August 26, 2025. Annonce • Aug 06
Madhya Bharat Agro Products Limited, Annual General Meeting, Sep 02, 2025 Madhya Bharat Agro Products Limited, Annual General Meeting, Sep 02, 2025, at 15:00 Indian Standard Time. Board Change • Aug 01
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 4 highly experienced directors. Independent Director Gopal Inani was the last director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment. Reported Earnings • Jul 14
First quarter 2026 earnings released: EPS: ₹3.22 (vs ₹1.31 in 1Q 2025) First quarter 2026 results: EPS: ₹3.22 (up from ₹1.31 in 1Q 2025). Revenue: ₹4.13b (up 106% from 1Q 2025). Net income: ₹282.1m (up 146% from 1Q 2025). Profit margin: 6.8% (up from 5.7% in 1Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 32% per year but the company’s share price has increased by 36% per year, which means it is well ahead of earnings. New Risk • Jun 23
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks High level of debt (76% net debt to equity). Share price has been volatile over the past 3 months (7.5% average weekly change). Valuation Update With 7 Day Price Move • Jun 23
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to ₹417, the stock trades at a trailing P/E ratio of 63.5x. Average trailing P/E is 28x in the Chemicals industry in India. Total returns to shareholders of 161% over the past three years. Valuation Update With 7 Day Price Move • May 27
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₹322, the stock trades at a trailing P/E ratio of 63.3x. Average trailing P/E is 26x in the Chemicals industry in India. Total returns to shareholders of 101% over the past three years. Buy Or Sell Opportunity • May 12
Now 21% overvalued after recent price rise Over the last 90 days, the stock has risen 7.3% to ₹298. The fair value is estimated to be ₹247, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 16% over the last 3 years. Earnings per share has declined by 24%. Buy Or Sell Opportunity • Feb 19
Now 23% overvalued after recent price rise Over the last 90 days, the stock has risen 34% to ₹298. The fair value is estimated to be ₹242, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 16% over the last 3 years. Earnings per share has declined by 24%. Reported Earnings • Jan 16
Third quarter 2025 earnings released: EPS: ₹2.04 (vs ₹0.15 in 3Q 2024) Third quarter 2025 results: EPS: ₹2.04 (up from ₹0.15 in 3Q 2024). Revenue: ₹2.85b (up 17% from 3Q 2024). Net income: ₹179.0m (up ₹166.0m from 3Q 2024). Profit margin: 6.3% (up from 0.5% in 3Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 24% per year but the company’s share price has increased by 82% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • Jan 03
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹238, the stock trades at a trailing P/E ratio of 74.6x. Average trailing P/E is 32x in the Chemicals industry in India. Total returns to shareholders of 453% over the past three years. Reported Earnings • Oct 16
Second quarter 2025 earnings released: EPS: ₹1.58 (vs ₹1.71 in 2Q 2024) Second quarter 2025 results: EPS: ₹1.58 (down from ₹1.71 in 2Q 2024). Revenue: ₹2.80b (flat on 2Q 2024). Net income: ₹138.4m (down 7.3% from 2Q 2024). Profit margin: 4.9% (down from 5.4% in 2Q 2024). Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has increased by 72% per year, which means it is well ahead of earnings. Buy Or Sell Opportunity • Oct 08
Now 20% overvalued Over the last 90 days, the stock has fallen 9.4% to ₹205. The fair value is estimated to be ₹171, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 35% over the last 3 years. Earnings per share has grown by 7.4%. Recent Insider Transactions • Oct 04
Non-Executive Non-Independent Chairman recently bought ₹5.4m worth of stock On the 27th of September, Mahendra Ostwal bought around 25k shares on-market at roughly ₹215 per share. This transaction amounted to 20% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger purchase from another insider worth ₹7.1m. Mahendra has been a buyer over the last 12 months, purchasing a net total of ₹8.2m worth in shares. New Risk • Oct 03
New minor risk - Dividend sustainability The company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 0.2% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (3.0x net interest cover). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (3.4% net profit margin). Recent Insider Transactions • Sep 21
Insider recently bought ₹3.0m worth of stock On the 17th of September, Rajendra Ostwal bought around 14k shares on-market at roughly ₹214 per share. This transaction increased Rajendra Ostwal's direct individual holding by 69x at the time of the trade. In the last 3 months, there was an even bigger purchase from another insider worth ₹7.1m. Insiders have collectively bought ₹9.9m more in shares than they have sold in the last 12 months. Recent Insider Transactions • Aug 31
MD & Director recently bought ₹7.1m worth of stock On the 27th of August, Pankaj Ostwal bought around 32k shares on-market at roughly ₹222 per share. This transaction amounted to 14% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Pankaj's only on-market trade for the last 12 months. Annonce • Aug 20
Madhya Bharat Agro Products Limited, Annual General Meeting, Sep 20, 2024 Madhya Bharat Agro Products Limited, Annual General Meeting, Sep 20, 2024, at 11:00 Indian Standard Time. Reported Earnings • Jul 30
First quarter 2025 earnings released: EPS: ₹1.31 (vs ₹0.82 in 1Q 2024) First quarter 2025 results: EPS: ₹1.31 (up from ₹0.82 in 1Q 2024). Revenue: ₹2.02b (up 36% from 1Q 2024). Net income: ₹114.9m (up 59% from 1Q 2024). Profit margin: 5.7% (up from 4.9% in 1Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has increased by 90% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • May 14
Full year 2024 earnings released: EPS: ₹2.84 (vs ₹14.17 in FY 2023) Full year 2024 results: EPS: ₹2.84 (down from ₹14.17 in FY 2023). Revenue: ₹8.28b (down 16% from FY 2023). Net income: ₹248.4m (down 80% from FY 2023). Profit margin: 3.0% (down from 13% in FY 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has increased by 123% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Mar 01
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₹288, the stock trades at a trailing P/E ratio of 52.9x. Average trailing P/E is 30x in the Chemicals industry in India. Total returns to shareholders of 1,365% over the past three years. Reported Earnings • Feb 15
Third quarter 2024 earnings released: EPS: ₹0.15 (vs ₹4.42 in 3Q 2023) Third quarter 2024 results: EPS: ₹0.15 (down from ₹4.42 in 3Q 2023). Revenue: ₹2.44b (down 15% from 3Q 2023). Net income: ₹13.0m (down 97% from 3Q 2023). Profit margin: 0.5% (down from 14% in 3Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 45% per year but the company’s share price has increased by 136% per year, which means it is tracking significantly ahead of earnings growth. Recent Insider Transactions • Dec 13
Non-Executive Independent Director recently sold ₹281k worth of stock On the 8th of December, Bheru Ostwal sold around 1k shares on-market at roughly ₹281 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger sale worth ₹2.7m. Insiders have been net sellers, collectively disposing of ₹2.9m more than they bought in the last 12 months. Recent Insider Transactions • Nov 28
Non-Executive Independent Director recently sold ₹2.7m worth of stock On the 21st of November, Bheru Ostwal sold around 10k shares on-market at roughly ₹266 per share. This transaction amounted to 5.6% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months. Reported Earnings • Oct 22
Second quarter 2024 earnings released: EPS: ₹3.41 (vs ₹3.72 in 2Q 2023) Second quarter 2024 results: EPS: ₹3.41 (down from ₹3.72 in 2Q 2023). Revenue: ₹2.79b (up 12% from 2Q 2023). Net income: ₹149.3m (down 54% from 2Q 2023). Profit margin: 5.3% (down from 13% in 2Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 60% per year but the company’s share price has increased by 177% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Oct 20
Investor sentiment deteriorates as stock falls 47% After last week's 47% share price decline to ₹319, the stock trades at a trailing P/E ratio of 13.6x. Average trailing P/E is 28x in the Chemicals industry in India. Total returns to shareholders of 966% over the past three years. Upcoming Dividend • Sep 11
Upcoming dividend of ₹0.50 per share at 0.1% yield Eligible shareholders must have bought the stock before 18 September 2023. Payment date: 26 October 2023. Payout ratio is a comfortable 1.8% but the company is not cash flow positive. Trailing yield: 0.1%. Lower than top quartile of Indian dividend payers (1.3%). Lower than average of industry peers (0.8%). Annonce • Aug 31
Madhya Bharat Agro Products Limited, Annual General Meeting, Sep 26, 2023 Madhya Bharat Agro Products Limited, Annual General Meeting, Sep 26, 2023, at 11:00 Indian Standard Time. Agenda: To consider and adopt (a) the audited financial statement of the Company for the financial year ended March 31, 2023 and the reports of the Board of Directors and Auditors thereon; to declare dividend on equity shares for the Financial Year 2022-23; to appoint a Director in place of Praveen Ostwal, who retires by rotation and being eligible, offers himself for re-appointment; to approve and ratify the authority of Board of directors in fixing remuneration of the Cost Auditor(s) for the financial year ending 31st March 2024; and to transact other business. Reported Earnings • Aug 08
First quarter 2024 earnings released: EPS: ₹1.65 (vs ₹6.55 in 1Q 2023) First quarter 2024 results: EPS: ₹1.65 (down from ₹6.55 in 1Q 2023). Revenue: ₹1.50b (down 30% from 1Q 2023). Net income: ₹72.4m (down 75% from 1Q 2023). Profit margin: 4.8% (down from 14% in 1Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 69% per year but the company’s share price has increased by 166% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • Apr 26
Full year 2023 earnings released: EPS: ₹28.35 (vs ₹13.01 in FY 2022) Full year 2023 results: EPS: ₹28.35 (up from ₹13.01 in FY 2022). Revenue: ₹9.87b (up 101% from FY 2022). Net income: ₹1.24b (up 118% from FY 2022). Profit margin: 13% (up from 12% in FY 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 76% per year but the company’s share price has increased by 168% per year, which means it is tracking significantly ahead of earnings growth. Board Change • Mar 01
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 4 experienced directors. 4 highly experienced directors. Independent Director Gopal Inani was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Jan 24
Third quarter 2023 earnings released: EPS: ₹8.84 (vs ₹5.23 in 3Q 2022) Third quarter 2023 results: EPS: ₹8.84 (up from ₹5.23 in 3Q 2022). Revenue: ₹2.90b (up 51% from 3Q 2022). Net income: ₹387.1m (up 69% from 3Q 2022). Profit margin: 13% (up from 12% in 3Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 74% per year but the company’s share price has increased by 163% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • Nov 05
Second quarter 2023 earnings released: EPS: ₹14.86 (vs ₹2.12 in 2Q 2022) Second quarter 2023 results: EPS: ₹14.86 (up from ₹2.12 in 2Q 2022). Revenue: ₹2.49b (up 188% from 2Q 2022). Net income: ₹325.5m (up 251% from 2Q 2022). Profit margin: 13% (up from 11% in 2Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 68% per year but the company’s share price has increased by 135% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Oct 18
Investor sentiment deteriorated over the past week After last week's 47% share price decline to ₹481, the stock trades at a trailing P/E ratio of 13.6x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 508% over the past three years. Upcoming Dividend • Sep 09
Upcoming dividend of ₹0.50 per share Eligible shareholders must have bought the stock before 16 September 2022. Payment date: 29 October 2022. Payout ratio is a comfortable 1.4% but the company is not cash flow positive. Trailing yield: 0.1%. Lower than top quartile of Indian dividend payers (1.5%). Lower than average of industry peers (0.7%). Annonce • Aug 25
Madhya Bharat Agro Products Limited Appoints Gopal Inani as Independent Director The board of directors of Madhya Bharat Agro Products Limited approved the appointment of Mr. Gopal Inani for regularized as an Independent Director of the company of the company for the five consecutive years. Mr. Gopal Inani aged 65 years, is a Mechanical Engineer from board of Technical Education, Rajasthan and having 37 years experience in various companies as under: UltraTech Cement (Unit: Vikram Cement Works, KHOR, Neemuch, M.P.) from October 1985 to February 2017, Senior Manager (Mechanical). Dhar Cement Limited, Jeerabad, Manawar (M.P.) from December 1983 to October 1985, worked as Assistant Engineer (Mechanical). Mewar Sugar Mills, Bhupal Sagar, Chittorgarh (Rajasthan) from March 1980 to December 1983, worked as Junior Engineer (Mechanical). He played vital role in implementation of various safety standards at plant level and worked on implementation of various system i.e. ISO 9001 for quality, 14001 for environment, OHSAS 18001 for safety and SA 8000 for social accountability. He has also been responsible for statuary compliances of Indian Railway, BIS and legal metrological rules with respect to cement industries. He has also served as a director on the board of Shri Ganpati Fertilizers Limited and krishna Phoschem Limited. He is chairman of the stakeholder relationship committee, corporate social responsibility commmitee of the company and also member of audit committee and nomination remuneration committee. Annonce • Aug 24
Madhya Bharat Agro Products Limited, Annual General Meeting, Sep 26, 2022 Madhya Bharat Agro Products Limited, Annual General Meeting, Sep 26, 2022, at 15:30 Indian Standard Time. Agenda: To consider and adopt (a) the audited financial statement of the Company for the financial year ended March 31, 2022 and the reports of the Board of Directors and Auditors thereon; to declare dividend on equity shares for the Financial Year 2021-22; to appoint a Director in place of Mr. Sourabh Gupta (DIN: 07177647), who retires by rotation and being eligible, offers himself for re-appointment and in this regard; To appoint new statutory Auditor namely M/s Ashok Kanther & Associates, Chartered Accountants in place of outgoing statutory auditors namely M/S Rajneesh Kanther & Associates, Chartered Accountants whose five year term expires with the conclusion of upcoming 25 AGM of the company; and to transact other matters. Reported Earnings • Jul 31
First quarter 2023 earnings released: EPS: ₹13.09 (vs ₹3.78 in 1Q 2022) First quarter 2023 results: EPS: ₹13.09 (up from ₹3.78 in 1Q 2022). Revenue: ₹2.13b (up 217% from 1Q 2022). Net income: ₹286.7m (up 246% from 1Q 2022). Profit margin: 14% (up from 12% in 1Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has increased by 130% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • Jun 03
Full year 2022 earnings released: EPS: ₹26.03 (vs ₹9.24 in FY 2021) Full year 2022 results: EPS: ₹26.03 (up from ₹9.24 in FY 2021). Revenue: ₹4.92b (up 165% from FY 2021). Net income: ₹570.2m (up 182% from FY 2021). Profit margin: 12% (in line with FY 2021). Over the last 3 years on average, earnings per share has increased by 48% per year but the company’s share price has increased by 135% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • May 11
Investor sentiment improved over the past week After last week's 17% share price gain to ₹551, the stock trades at a trailing P/E ratio of 28.1x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 1,010% over the past three years. Board Change • Apr 27
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 3 experienced directors. 4 highly experienced directors. Non-Executive Woman Independent Director Shruti Babel was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Board Change • Apr 02
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 3 experienced directors. 4 highly experienced directors. Non-Executive Woman Independent Director Shruti Babel was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Valuation Update With 7 Day Price Move • Mar 21
Investor sentiment improved over the past week After last week's 16% share price gain to ₹386, the stock trades at a trailing P/E ratio of 19.7x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 607% over the past three years. Reported Earnings • Feb 08
Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations Third quarter 2022 results: EPS: ₹10.45 (up from ₹1.65 in 3Q 2021). Revenue: ₹1.92b (up ₹1.60b from 3Q 2021). Net income: ₹228.9m (up ₹192.7m from 3Q 2021). Profit margin: 12% (in line with 3Q 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 38% per year but the company’s share price has increased by 78% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • Nov 11
Second quarter 2022 earnings released: EPS ₹4.24 (vs ₹3.74 in 2Q 2021) The company reported a solid second quarter result with improved earnings and revenues, although profit margins were weaker. Second quarter 2022 results: Revenue: ₹864.1m (up 58% from 2Q 2021). Net income: ₹92.9m (up 13% from 2Q 2021). Profit margin: 11% (down from 15% in 2Q 2021). The decrease in margin was driven by higher expenses. Valuation Update With 7 Day Price Move • Sep 28
Investor sentiment improved over the past week After last week's 15% share price gain to ₹208, the stock trades at a trailing P/E ratio of 20.2x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 371% over the past three years. Valuation Update With 7 Day Price Move • Sep 13
Investor sentiment improved over the past week After last week's 33% share price gain to ₹185, the stock trades at a trailing P/E ratio of 18x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 304% over the past three years. Upcoming Dividend • Sep 10
Upcoming dividend of ₹0.50 per share Eligible shareholders must have bought the stock before 17 September 2021. Payment date: 27 October 2021. Trailing yield: 0.3%. Lower than top quartile of Indian dividend payers (1.5%). Lower than average of industry peers (0.7%). Valuation Update With 7 Day Price Move • Aug 30
Investor sentiment improved over the past week After last week's 20% share price gain to ₹172, the stock trades at a trailing P/E ratio of 16.7x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 244% over the past three years. Reported Earnings • Aug 02
First quarter 2022 earnings released: EPS ₹3.78 (vs ₹2.71 in 1Q 2021) The company reported a solid first quarter result with improved earnings and revenues, although profit margins were flat. First quarter 2022 results: Revenue: ₹673.3m (up 36% from 1Q 2021). Net income: ₹82.9m (up 40% from 1Q 2021). Profit margin: 12% (in line with 1Q 2021). Valuation Update With 7 Day Price Move • Jul 27
Investor sentiment improved over the past week After last week's 17% share price gain to ₹144, the stock trades at a trailing P/E ratio of 15.6x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 236% over the past three years. Valuation Update With 7 Day Price Move • Jun 30
Investor sentiment improved over the past week After last week's 21% share price gain to ₹127, the stock trades at a trailing P/E ratio of 13.8x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 216% over the past three years. Reported Earnings • Jun 19
Full year 2021 earnings released: EPS ₹9.24 (vs ₹6.77 in FY 2020) The company reported a solid full year result with improved earnings and revenues, although profit margins were flat. Full year 2021 results: Revenue: ₹1.86b (up 42% from FY 2020). Net income: ₹202.4m (up 36% from FY 2020). Profit margin: 11% (in line with FY 2020). Over the last 3 years on average, earnings per share has increased by 33% per year whereas the company’s share price has increased by 34% per year. Valuation Update With 7 Day Price Move • Jun 08
Investor sentiment improved over the past week After last week's 24% share price gain to ₹103, the stock trades at a trailing P/E ratio of 12.2x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 105% over the past three years. Valuation Update With 7 Day Price Move • Mar 24
Investor sentiment improved over the past week After last week's 20% share price gain to ₹90.05, the stock trades at a trailing P/E ratio of 10.7x. Average trailing P/E is 16x in the Chemicals industry in India. Total returns to shareholders of 115% over the past three years. Is New 90 Day High Low • Feb 18
New 90-day high: ₹73.95 The company is up 4.0% from its price of ₹71.00 on 20 November 2020. The Indian market is up 21% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 15% over the same period. Reported Earnings • Feb 07
Third quarter 2021 earnings released: EPS ₹1.65 (vs ₹2.65 in 3Q 2020) The company reported a poor third quarter result with weaker earnings, revenues and profit margins. Third quarter 2021 results: Revenue: ₹318.8m (down 6.8% from 3Q 2020). Net income: ₹36.2m (down 38% from 3Q 2020). Profit margin: 11% (down from 17% in 3Q 2020). Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth. Annonce • Jan 31
Madhya Bharat Agro Products Limited to Report Q3, 2021 Results on Feb 06, 2021 Madhya Bharat Agro Products Limited announced that they will report Q3, 2021 results on Feb 06, 2021 Is New 90 Day High Low • Jan 04
New 90-day high: ₹72.95 The company is up 21% from its price of ₹60.50 on 06 October 2020. The Indian market is up 20% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 22% over the same period. Valuation Update With 7 Day Price Move • Nov 09
Market bids up stock over the past week After last week's 17% share price gain to ₹70.45, the stock is trading at a trailing P/E ratio of 8.8x, up from the previous P/E ratio of 7.5x. This compares to an average P/E of 15x in the Chemicals industry in India. Total returns to shareholders over the past three years are 10%. Annonce • Sep 19
Madhya Bharat Agro Products Limited to Report Q1, 2021 Results on Aug 21, 2020 Madhya Bharat Agro Products Limited announced that they will report Q1, 2021 results on Aug 21, 2020 Annonce • Jul 17
Madhya Bharat Agro Products Limited to Report Q3, 2020 Results on Feb 08, 2020 Madhya Bharat Agro Products Limited announced that they will report Q3, 2020 results on Feb 08, 2020 